Back to Results
First PageMeta Content
Mood disorders / Atypical antipsychotics / Piperazines / Antipsychotic / Schizophrenia / Bipolar disorder / Comparative effectiveness research / Mental disorder / Agency for Healthcare Research and Quality / Psychiatry / Abnormal psychology / Psychopathology


Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults
Add to Reading List

Open Document

File Size: 1,63 MB

Share Result on Facebook

City

Services Sylmar / Rockville / Raleigh / Vancouver / Sacramento / /

Company

M. Clancy / Agency for Healthcare Research / /

Country

United States / /

/

Event

FDA Phase / /

Facility

M.P.H. Columbia University Medical Center / M.D. NYS Psychiatric Institute / Ph.D. University of Maryland School / Addictions Research Institute / M.D. National Institute of Mental Health Bethesda / Translational Science Institute / Behavioral Sciences UC Davis M.I.N.D. Institute / University of Alberta EPC / UNC Sheps Center / /

IndustryTerm

Bipolar disorder Treatment / food preferences / Online Prioritization Exercises Appendix G. Additional Relevant Characteristics / protective services / health care technologies / health care services / healthcare / social services / treatment of major depressive disorder / therapy for major depressive disorder / technology assessments / online prioritization tools / treatment of agitation Acute schizophrenia Bipolar disorder / assistive technology / /

MedicalCondition

conduct disorder / disruptive behavior disorder / autism Schizophrenia Bipolar disorder / Acute schizophrenia Schizophrenia Bipolar disorder / antipsychotics Generic Name Aripiprazole Asenapine Clozapine Iloperidone Olanzapine Paliperidone Quetiapine Risperidone Ziprasidone Indications Schizophrenia Bipolar disorder / schizoaffective disorder / disruptive behavior disorders / illness / MS / pervasive developmental disorder / Asperger syndrome / pervasive developmental disorders / Rett syndrome / schizophrenia-related psychoses / ADHD / Tourette syndrome / schizophrenia / antipsychotics Generic Name Chlorpromazine Droperidol Fluphenazine Haloperidol Loxapine Perphenazine Pimozide Prochlorperazine Thiothixene Thioridazine Trifluoperazine Indications Schizophrenia Bipolar disorder / mania / post-traumatic stress disorder / autistic disorder / Attention deficit hyperactivity disorder / oppositional defiant disorder / I mania Schizophrenia Schizoaffective disorder Schizophrenia Bipolar disorder / anorexia nervosa / sleep disorders / Schizophrenia Bipolar disorder / depression / childhood disintegrative disorder / obsessive-compulsive disorder / Bipolar disorder / disorders / /

MedicalTreatment

Adjunctive therapy / /

Organization

Department of Psychiatry / U.S. Department of Health and Human Services / National Alliance / Division of Psychiatry Products Silver Spring / University of Maryland School of Pharmacy Baltimore / Food and Drug Administration / Center for Outcomes / UNC Sheps Center for Health Services Research / M.P.H. Columbia University Medical Center New York / M.R.P. Task Order Officer Center for Outcomes / NYS Psychiatric Institute New York / CDC National Center on Birth Defects and Development Disabilities Atlanta / University of Alberta EPC / Institute of Mental Health Bethesda / Practice Program Center for Outcomes / RTI-UNC Evidence-based Practice Center / Translational Science Institute Boston / /

Person

H. Daniel E. Jonas / Jennifer Seida / Penelope Knapp / Sharon Barrell / Alan R. Ellis / M.D. Lissette Saavedra / Debra Dihoff / Jean Slutsky / Stephanie Chang / Mark Olfson / Sonia Tyutyulkova / P.H. Brian Sheitman / Bradley N. Gaynes / H. Timothy S. Carey / Jana Davidson / Robert Christian / M.P.H. Meera Viswanathan / Fay Kagan / Loraine Monroe / Elisabeth Kato / W. Carol Woodell / Shannon Brode / Laurel Leslie / Tiffany Farchione / Carolyn M. Clancy / Maria Tobin / Teri Brister / Laurence Greenhill / Christiane Voisin / Mattias Jonsson / /

Position

Publications Specialist / Editor / Task Order Officer / Governor / Director / Executive / Contents Executive / Director Agency / /

Product

Fluphenazine / Haloperidol / Loxapine / Droperidol / Risperidone / Olanzapine / Clozapine / Thiothixene / Perphenazine / Prochlorperazine / ES-1 / /

ProvinceOrState

California / /

PublishedMedium

the Comparative Effectiveness Review / /

Technology

health care technologies / /

URL

www.ahrq.gov / www.effectivehealthcare.ahrq.gov/reports/final.cfm / /

SocialTag